
ARRAY-COMPARATIVE GENOMIC HYBRIDIZATION
RESULTS IN CLINICALLY AFFECTED CASES
WITH APPARENTLY BALANCED CHROMOSOMAL
REARRANGEMENTS Satkin NB, Karaman B, Ergin S, Kayserili H, Kalelioglu IH, Has R, Yuksel A, Basaran S *Corresponding Author: Nihan B. Satkin, Ph.D., Department of Medical Genetics, Istanbul University
Faculty of Medicine, Millete Street, 34093, Istanbul, Turkey. Tel.: +90-536-561-0313.
Fax: +90-212-414-2000. E-mail: bilgenihan@gmail.com page: 25
|
MATERIALS AND METHODS
The study contains the cytogenetic and array-comparative
genomic hybridization (aCGH) results of 34 affected
patients (13 prenatal, 21 postnatal) carrying ABCRs and
76 of family members (including parents and siblings)
investigated between the years 2001-2017. All cases were
examined, counseled and laboratory work was performed
at the Department of Medical Genetics, Istanbul University
Faculty of Medicine, Istanbul, Turkey. Fetal ultrasonography
(USG) and invasive procedures [one chorionic
villus sampling (CVS), four fetal blood sampling (FSB)
and eight by amniocentesis (AC)] were performed at the
Perinatology Division of the Obstetrics and Gynecology
Department, Istanbul University Faculty of Medicine, Istanbul,
Turkey.
Lymphocytes cultures of peripheral and cord blood
samples, amniotic fluid and chorionic villus samples using
short and long-term cell cultures were performed according
to traditional techniques. Routine cytogenetic analyses were
performed on metaphase chromosomes at 550-600 banding
levels using Giemsa-Pancreatin-Leishman’s banding.
Chromosomal Microarray Analysis. Genomic DNA
was extracted using High Pure polymerase chain reaction
(PCR) Template Preparation kit following the manufacturer’s
protocol (Roche Diagnostics, Indianapolis, IN, USA).
Chromosomal microarray testing was performed in patients
using NimbleGen 3 × 1.4 M Whole-Genome Tiling Array,
which has 1,400,000 copy number variations (CNV) probes
across the entire genome according to the manufacturer’s
instructions (Roche NimbleGen, Madison, WI, USA).
The SurePrint G3+SNP (single nucleotide polymorphism)
Human CGH Microarray (4 × 180 K) dual-color
array containing more than 170,334 distinct biological
probes with 13 kb genome-wide median probes spacing
was carried out following the protocols provided by the
manufacturer (Agilent Technologies Inc., Santa Clara,
CA, USA) in parents to detect inheritance and for confirmation
of detected CNVs that were larger than 1 Mb in
index cases.
Aberration calls using Nexus Copy Number (Bio-
Discovery, El Segundo, CA, USA) was implemented following
thresholds for copy numbers; 100 kb gains, 50 kb
losses across the genome with a minimum of 25 markers
to make the call. For regions of known significance, the
minimal setting was 25 kb and 25 markers for gains and
losses. Detected variations were classified according to
the American College of Medical Genetics and Genomics
(ACMG) guidelines [8,9]. Only likely pathogenic or
pathogenic variations were reported and uncertain CNVs
were evaluated by taking into consideration of ACMG
classification scores [8,9].
This study was reviewed and approved by the Ethics
Committee of the Istanbul Medical Faculty [N. 08/13].
Written informed consent was obtained from all subjects
or their legal guardians included in this study.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|